Search results for: revocation

The Unified Patent Court

What is the Unified Patent Court (UPC) and when will it open? The UPC is a forum for central litigation of a unitary patent. It will also have jurisdiction over European patents that are not opted out...

Intellectual Property – If a Tree Falls in a Forest and No One Is Around To Hear It, Does It Make a Sound?

The title of this piece quotes an interesting philosophical question.  In the world of patents, this question is somewhat analogous to the question “to what extent does prior use of an inventio...

Unified Patent Court and Unitary Patent

Streamline infringement and validity disputes across different EU Member States On 20 July 2020, the UK officially withdrew from the proposed Unified Patent Court (UPC) system. In a parliamentary writ...

Unified Patent Court & Unitary Patent

The European patent system is going through one of its biggest changes since the introduction of a European patent in the 1970s. The Unitary Patent (UP) and Unified Patent Court (UPC) fully entered in...

Supplementary Protection Certificates

We can help you secure a patent term extension to compensate for the time it takes for your new drug to pass clinical trials and receive marketing authorisation.  In many European countries, you�...

Third Party Observations

Third party observations are another tool that you can use alongside oppositions and national revocation actions.  Their purpose is to uphold your freedom to operate when it is challenged by a co...

Opposition Practice at the EPO – Advice for Patent Owners

Opposition proceedings at the EPO provide a time-limited opportunity for a third party to challenge the validity of a granted European patent centrally, with the aim of achieving revocation, or at lea...

Get Your Priorities Right – A Guide to Establishing and Maintaining a Valid Priority at the EPO

Background The patent priority system was established by the Paris Convention to provide an applicant with 1 year grace to get their foreign applications filed after filing their first (usually local)...

Oppositions at the European Patent Office – An Introduction | 15.12.20

Tuesday 15th December 2020, 2:00pm (London UK – BST) 45mins What will the talk cover? Gill Jennings & Every has one of the most experienced and active patent opposition practices in Europe, ...

GJE Partner, Arnie Clarke, Leads Successful Landmark Opposition Attack of Teva’s Key 2030 Patent (EP 2 949 335) On Behalf of Mylan

Arnie Clarke has recently been involved in the ground-breaking appeal relating to Teva’s key 2030 patent (EP 2 949 335).  Acting on behalf of Mylan, in front of the EPO board of appeal 3.3.04, ...